Tempest Therapeutics, Inc. — Director's Dealing 2016

Jan 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2015-12-31

Reporting Person: ALDRICH RICHARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-19	Common Stock	G	200000	$0.00	Disposed	601979	Direct
2015-10-19	Common Stock	G	200000	$0.00	Acquired	200000	Indirect
2015-12-31	Common Stock	A	1087	$0.00	Acquired	603066	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22350	Indirect
Common Stock	175481	Indirect

Footnotes

F1: The Reporting Person disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F3: The trustee of the Richard H. Aldrich 2005 Revocable Trust is the Reporting Person and he exercises sole voting and investment power over the shares of record held by the trust.

F4: The trustee of the Richard H. Aldrich Irrevocable Trust of 2011 is the Reporting Person's spouse, Nichole Aldrich, and she exercises sole voting and investment power over the shares of record held by the trust.